… We describe results under real-life conditions of a sequential treatment strategy, before
the era of immunotherapy. All patients were treated according to their prognostic score (either …

… Real-life analysis of overall survival (OS) trends among metastatic breast cancer (MBC)
patients may help define medical needs and evaluate the impact of public health investments. …

… information on how these patients are managed in real life and how outcomes relate to …
in a broad range of patients, 11 we aim to assess real-life outcomes in patients who have …

… and survival in non-small cell lung cancer (NSCLC) patients. … and overall survival in
non-resectable (nr)NSCLC patients by … The survival improved in the last decade, and women and …

… Health‐related quality of life (HRQoL) has been shown to be a prognostic factor for cancer
survival in randomized clinical trials and observational “real‐world” cohort studies; however, it …

… and real-life outcomes of the largest myxofibrosarcoma cohort to date including 908 patients…
factors and describe real-life outcomes of a large cohort of 908 MFS patients obtained from …

… Surviving patients were censored at 31 January 2019. Crude OS stratified by year of … patients
about their prognosis and to compare survival of real-life patients to survival of trial patients. …

… survival benefit in clinical practice. Our aim was to clarify whether improvements in mRCC
survival were also present in a “real-world” cohort of patients… OS between patients who started …

… outcomes in randomized trials may be different from those in real-life clinical practice. The …
and survival in patients with metastatic Renal Cell Carcinoma (mRCC) in a real world setting. …

Purpose High-dose chemotherapy with autologous stem cell transplantation (ASCT) is
considered to be the only curative treatment option for patients with refractory or relapsed diffuse …